Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Short Versus Long-term Androgen Deprivation Therapy Combined With Salvage Radiotherapy in Prostate Cancer Patients With Biochemical Recurrence After Prostatectomy: a Multicentre Phase III Randomised Controlled Trial

NCT05781217 is registered in ClinicalTrials.gov with Instituto de Investigación en Oncología Radioterápica - Fundación Española de Oncología Radioterápic as lead sponsor.

NCT NCT05781217
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05781217 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Short Versus Long-term Androgen Deprivation Therapy Combined With Salvage Radiotherapy in Prostate Cancer Patients With Biochemical Recurrence After Prostatectomy: a Multicentre Phase III Randomised Controlled Trial
Lead sponsor
Instituto de Investigación en Oncología Radioterápica - Fundación Española de Oncología Radioterápic
Phase
Phase 3
Overall status
Recruiting
Start date
March 14, 2023
Completion date
December 31, 2032
Enrollment
534 (estimated)
Sites
17

Conditions

As the registry lists them; a condition with its own page is linked.

androgen deprivation therapy, biochemical recurrence, metastases-free survival, prostate cancer, salvage radiotherapy